山东威高集团医用高分子制品股份有限公司（威高股份，股票代码：01066）于2026年8月26日公告，已于香港联交所场内回购H股合计350,000股。回购价格介乎每股3.34港元至3.38港元，合计付出约1,177,550港元（约117.76万港元），回购股份约占本次交易前已发行股本的0.0078%。
本次回购完成后，公司已发行股本由4,459,837,924股减少至4,459,487,924股，库存股从62,494,400股增至62,844,400股，总发行股份数仍为4,522,332,324股。公司于2026年5月29日通过的购回授权最多可回购446,464,632股，目前累计回购股数达5,518,400股，占授权通过当日已发行股本约1.236%。公司同时确认已遵守香港联合交易所证券上市规则及相关法律法规要求。本公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.